Publications

Selected Publications (2005-2011)

136. Siebert U, Alagoz O, Bayoumi AM, Jahn B, Owens DK, Cohen DJ, Kuntz KM. State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group – Part 5. ISPOR 2011. Internet: http://www.ispor.org/taskforces/GRPModelingTf.asp

135. Sels J, Tonino P, Siebert U, Fearon W, Van’t Veer M, De Bruyne B, Pijls N. Fractional Flow Reserve in Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction: Experience From the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) Study. J Am Coll Cardiol Intv 2011;4(11):1183-9.

134. Schnell-Inderst P, Hunger T, Hintringer K, Schwarzer R, Seifert-Klauss V, Gothe H, Wasem J, Siebert U. Individuelle Gesundheitsleistungen. Schriftenreihe des Deutschen Instituts für Medizinische Dokumentation und Information im Auftrag des Deutschen Bundesministeriums für Gesundheit. Health Technology Assessment. Vol. 113 (1. Auflage). Köln: DAHTA@DIMDI, 2011.

133. Ammenwerth E, Schnell-Inderst P, Hörbst A. Patient Empowerment by Electronic Health Records: First Results of a Systematic Review on the Benefit of Patient Portals. e-health Across Borders without Boundaries. EFMI Special Topic Conference (STC), April 14-15. Laško, Slovenia, Studies in Health Technology and Informatics. Amsterdam: IOS Press 2011; 165:63-67.

132. Siebert U. [Transparent Decisions in Public Health Using Systematic Decision Analysis]. [German]. In: Schwartz FW, Badura B, Busse R, Leidl R, Raspe H, Siegrist J, Walter U (eds.): [The Public Health Book. Health and Health Care]. 3nd ed. Urban & Fischer: Munich, 2011 [in press].

131. Dams J, Bornschein B, Reese JP, Conrads-Frank A, Oertel W, Siebert U, Dodel R. Modelling the cost effectiveness of treatments for Parkinson´s Disease – A methodological review. Pharmacoeconomics 2011;29(12):1025-49.

130. Oberaigner W, Siebert U, Horninger W, Klocker H, Bektic J, Schäfer G, Frauscher F, Schennach H, Bartsch G. Prostate-specific antigen testing in Tyrol, Austria: prostate cancer mortality reduction was supported by an update with mortality data up to 2008. Int J Public Health 2011 [epub ahead of print].

129. Oberaigner W, Siebert U. Do women with cancer have better survival as compared to men after adjusting for staging distribution? Eur J Public Health 2011;21(3)291:387-391.

128. Oberaigner W, Daniaux M, Geiger-Gritsch S, Knapp R, Siebert U, Buchberger W. Introduction of organised mammography screening in Tyrol: results following first year of complete rollout. BMC PH 2011;11(673).

127. Baeuml J, Bose-O’Reilly S, Lettmeier B, Maydl A, Messerer K, Roider G, Drasch G, Siebert U. Applicability of two mobile analysers for mercury in urine in small-scale gold mining areas. International Journal Hygiene Environmental Health 2011;215(1):64-7.

126. Goehler A, Geisler BP, Manne JM, Jahn B, Conrads-Frank A, Schnell-Inderst P, Gazelle GS, Siebert U. Decision-Analytic models to simulate health outcomes and costs in heart failure: a systematic review. Pharmacoeconomics 2011;29(9):753-69.

125. Jahn R, Diehm C, Driller E, Hessel F, Ommen O, Pfaff H, Siebert U, Pittrow D, Wasem J, Neumann A. Effect of guideline-orientation on the outcomes of peripheral arterial disease in primary care. Current Medical Research and Opinion 2011;27(6)286:1183-1190.

124. Sroczynski G, Schnell-Inderst P, Muhlberger N, Lang K, Aidelsburger P, Wasem J, Mittendorf T, Engel J, Hillemanns P, Petry KU, Kramer A, Siebert U. Cost-effectiveness of primary HPV screening for cervical cancer in Germany – a decision analysis. Eur J Cancer 2011;47(11):1633-46.

123. Krobot KJ, Wagner A, Siebert U. Risk factor levels, risk factor combinations, and residual coronary risk: population-based estimates for secondary prevention patients using statins European Journal of Cardiovascular Prevention & Rehabilitation 2011 [epub ahead of print].

122. Mickisch GH, Schwander B, Escudier B, Bellmunt J, Maroto J P, Porta C, Walzer S, Siebert, U. Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy. ClinicoEconomics and Outcomes Research 2011;3:19-27.

121. von Campenhausen S, Winter Y, Silva AR, Sampaio C, Ruzicka E, Barone P, Poewe W, Guekht A, Mateus C, Pfeiffer KP, Berger K, Skoupa J, Botzel K, Geiger-Gritsch S, Siebert U, Balzer-Geldsetzer M, Oertel WH, Dodel R, Reese JP. Costs of illness and care in Parkinson’s Disease: An evaluation in six countries. Eur Neuropsychopharmacol 2011;21(2):180-91.

120. Oberaigner W, Buchberger W, Frede T, Daniaux M, Knapp R, Marth C, Siebert U. Introduction of organised mammography screening in Tyrol: results of a one-year pilot phase. BMC Public Health 2011;11(91):1-28.

119. Steckling N, Boese-O’Reilly S, Gradel C, Gutschmidt K, Shinee E, Altangerel E, Badrakh B, Bonduush I, Surenjav U, Ferstl P, Roider G, Sakamoto M, Sepai O, Drasch G, Lettmeier B, Morton J, Jones K, Siebert U, Hornberg C. Mercury exposure in female artisanal small-scale gold miners (ASGM) in Mongolia: An analysis of human biomonitoring (HBM) data from 2008. Sci Total Environ 2011;409(5):994-1000.

118. Fearon WF, Bornschein B, Tonino PA, Gothe RM, Bruyne BD, Pijls NH, Siebert U. Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. Circulation 2010;122(24):2545-50.

117. Caro JJ, Nord E, Siebert U, McGuire A, McGregor M, Henry D, de Pouvourville G, Atella V, Kolominsky-Rabas P. The efficiency frontier approach to economic evaluation of health-care interventions. Health Econ 2010;19(10):1117-27.

116. Caro JJ, Nord E, Siebert U, McGuire A, McGregor M, Henry D, de Pouvourville G, Atella V, Kolominsky-Rabas P. IQWiG methods – a response to two critiques. Health Econ 2010;19(10):1137-8.

115. Siebert U, Schnell-Inderst P, Hintringer K. Health Technology Assessment. medicine & health 2011. GoingInternational Polak, G., 2010;229-31.

115. Oberbichler S, Memelink M, Wozak F, Jahn B, Schabetsberger T, Hoerbst A, Siebert U. INSYDE – Integration of Health System Data and Exchange – A Status Report, OCG Books 2010;264:181-87.

114. Neumann PJ, Drummond MF, Jonsson B, Luce BR, Schwartz JS, Siebert U, Sullivan SD. Evaluating HTA principles – Letters to the Editor. Int J Technol Assess Health Care 2010;26(4):429-30.

113. Nuijten M, Heigener D, Bischoff H, Chouaid C, Vergnenègre A, Carpeño J, Aultman R, Walzer S, Siebert U. Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer. Lung Cancer 2010;69(Supplement 1):4-10.

112. Luce BR, Drummond M, Jonsson B, Neumann PJ, Schwartz JS, Siebert U, Sullivan SD. EBM, HTA, and CER: clearing the confusion. Milbank Q 2010;88(2):256-76.

111. Schmidt T, Mühlberger N, Chemelli-Steingruber IE, Strasak A, Kofler B, Chemelli A, Siebert U. Benefit, risks and cost-effectiveness of screening for abdominal aortic aneurysm. Rofo: Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 2010;182(7):573-80.

110. Pijls NH, Fearon WF, Tonino PA, Siebert U, Ikeno F, Bornschein B, van’t Veer M, Klauss V, Manoharan G, Engstrom T, Oldroyd KG, Ver Lee PN, MacCarthy PA, De Bruyne B. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol 2010;56(3):177-84.

109. Verhoef TI, Redekop WK, Darba J, Geitona M, Hughes DA, Siebert U, de Boer A, Maitland-van der Zee AH, Barallon R, Briz M, Daly A, Haschke-Becher E, Kamali F, Kirchheiner J, Manolopoulos VG, Pirmohamed M, Rosendaal FR, van Schie RM, Wadelius M. A systematic review of cost-effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives. Pharmacogenomics 2010;11(7):989-1002.

108. Strasser B, Siebert U, Schobersberger W. Resistance training in the treatment of the metabolic syndrome: a systematic review and meta-analysis of the effect of resistance training on metabolic clustering in patients with abnormal glucose metabolism. Sports Med 2010;40(5):397-415.

107. Sroczynski G, Schnell-Inderst P, Mühlberger N, Lang K, Aidelsburger P, Wasem J, Mittendorf T, Engel J, Hillemanns P, Petry KU, Krämer A, Siebert U. [Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany]. Health Technology Assessment. Cologne: DIMDI, 2010;1-127.

106. Basner M, Siebert U. Markov processes for the prediction of aircraft noise effects on sleep. Medical Decision Making 2010; 30(2):275-89.

105. Jahn B, Theurl E, Siebert U, Pfeiffer KP. Tutorial in medical decision modeling incorporating waiting lines and queues using discrete event simulation. Value Health 2010;13(4):501-6.

104. Grander W, Dunser M, Stollenwerk B, Siebert U, Dengg C, Koller B, Eller P, Tilg H. C-reactive protein levels and post-ICU mortality in nonsurgical intensive care patients. Chest 2010;138(4):856-62.

103. Sroczynski G, Schnell-Inderst P, Mühlberger N, Lang K, Aidelsburger P, Wasem J, Mittendorf T, Engel J, Hillemanns P, Petry KU, Krämer A, Siebert U. [Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany]. GMS Health Technol Assess 2010;6(Doc05 ):1-13.

102. Ammenwerth E, Schnell-Inderst P, Siebert U. Vision and challenges of Evidence-Based Health Informatics: a case study of a CPOE meta-analysis. Int J Med Inform 2010;79(4):e83-8.

101. Stollenwerk B, Stock S, Siebert U, Lauterbach KW, Holle R. Uncertainty assessment of input parameters for economic evaluation: Gauss’s error propagation, an alternative to established methods. Med Decis Making 2010;30(3):304-13.

100. Oberaigner W, Buchberger W, Frede T, Knapp R, Marth C, Siebert U. Breast cancer incidence and mortality in Tyrol/Austria after fifteen years of opportunistic mammography screening. BMC Public Health 2010;10(1):86.

99. Konig A, Bleie O, Rieber J, Jung P, Schiele TM, Sohn HY, Leibig M, Siebert U, Klauss V. Intravascular ultrasound radiofrequency analysis of the lesion segment profile in ACS patients. Clin Res Cardiol 2010;99(2):83-91.

98. Sroczynski G, Esteban E, Conrads-Frank A, Schwarzer R, Mühlberger N, Wright D, Zeuzem Z, Siebert U. Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis C. J Viral Hep 2010;17(1):34-50.

97. Bose-O’Reilly S, Drasch G, Beinhoff C, Rodrigues-Filho S, Roider G, Lettmeier B, Maydl A, Maydl S, Siebert U. Health assessment of artisanal gold miners in Indonesia. Sci Total Environ 2010;408(4):713-25.

96. Bose-O’Reilly S, Drasch G, Beinhoff C, Tesha A, Drasch K, Roider G, Taylor H, Appleton D, Siebert U. Health assessment of artisanal gold miners in Tanzania. Sci Total Environ 2010;408(4):796-805.

95. International Working Group for HTA Advancement, Neumann PJ, Drummond MF, Jönsson B, Luce BR, Schwartz JS, Siebert U, Sullivan SD. Are Key Principles for improved health technology assessment supported and used by health technology assessment organizations? International Journal of Technology Assessment in Health Care 2010; 26(1):71-78.

94. Schnell-Inderst P, Schwarzer R, Gohler A, Grandi N, Grabein K, Stollenwerk B, Manne J, Klauss V, Siebert U, Wasem J. Prognostic value, clinical effectiveness, and cost-effectiveness of high-sensitivity C-reactive protein as a marker for major cardiac events in asymptomatic individuals: a health technology assessment report. Int J Technol Assess Health Care 2010;26(1):30-9.

93. Kollensperger M, Geser F, Ndayisaba JP, Boesch S, Seppi K, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Abele M, Klockgether T, Yekhlef F, Tison F, Daniels C, Deuschl G, Coelho M, Sampaio C, Bozi M, Quinn N, Schrag A, Mathias CJ, Fowler C, Nilsson CF, Widner H, Schimke N, Oertel W, Del Sorbo F, Albanese A, Pellecchia MT, Barone P, Djaldetti R, Colosimo C, Meco G, Gonzalez-Mandly A, Berciano J, Gurevich T, Giladi N, Galitzky M, Rascol O, Kamm C, Gasser T, Siebert U, Poewe W, Wenning GK. Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord 2010;25(15):2604-12.

92. Tonino PA, De Bruyne B, Pijls NHJ, Siebert U, Ikeno F, van’t Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF, for the FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. New England Journal of Medicine 2009;360(3):213-24.

91. Trikalinos TA, Siebert U, Lau J. Decision-analytic modelling to evaluate benefits and harms of medical tests. Medical Tests-White Paper Series. Rockville: Agency for Healthcare Research and Quality (AHRQ), 2009;1-15.

90. von Campenhausen S, Winter Y, Gasser J, Seppi K, Reese JP, Pfeiffer KP, Geiger-Gritsch S, Botzel K, Siebert U, Oertel WH, Dodel R, Poewe W. [Cost of illness and health service patterns in Morbus Parkinson in Austria]. Wien Klin Wochenschr 2009;121(17-18):574-82.

89. Schwarzer R, Schnell-Inderst P, Grabein K, Gohler A, Stollenwerk B, Grandi N, Klauss V, Wasem J, Siebert U. [Prognostic value and clinical effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac events]. Z Evid Fortbild Qual Gesundhwes 2009;103(6):319-29.

88. Johnson ML, Crown W, Martin BC, Dormuth CR, Siebert U. Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report – Part III. Value in Health 2009; 12(8):1062-1073.

87. Oberaigner W, Siebert U. Are survival rates for Tyrol published in the Eurocare studies biased? Acta Oncol 2009;48(7):984 – 991.

86. Konig A, Bleie O, Rieber J, Jung P, Schiele TM, Sohn HY, Leibig M, Siebert U, Klauss V. Intravascular ultrasound radiofrequency analysis of the lesion segment profile in ACS patients. Clin Res Cardiol 2010;99(2):83-91.

85. Cox E, Martin BC, Van Staa T, Garbe E, Siebert U, Johnson ML. Good research practices for comparative effectiveness research: Approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: The International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report-Part II. Value Health 2009;12(8):1053-1061.

84. Trikalinos TA, Siebert U, Lau J. Decision-analytic modeling to evaluate benefits and harms of medical tests: Uses and limitations. Med Decis Making 2009;29(5):E22-9.

83. Mehrhof F, Loffler M, Gelbrich G, Ozcelik C, Posch M, Hense HW, Keil U, Scheffold T, Schunkert H, Angermann C, Ertl G, Jahns R, Pieske B, Wachter R, Edelmann F, Wollert KC, Maisch B, Pankuweit S, Erbel R, Neumann T, Herzog W, Katus H, Muller-Tasch T, Zugck C, Dungen HD, Regitz-Zagrosek V, Lehmkuhl E, Stork S, Siebert U, Wasem J, Neumann A, Gohler A, Anker SD, Kohler F, Mockel M, Osterziel KJ, Dietz R, Rauchhaus M. A network against failing hearts–introducing the German “Competence Network Heart Failure”. Int J Cardiol 2010;145(1):135-8.

82. Konig A, Bleie O, Dudek D, Marso S, Rogers JH, Dave R, Tanaka K, Siebert U, Wijns W, Klauss V. Coronary plaque dimensions and composition by intravascular ultrasound radio frequency lesion segment analysis in stable and unstable angina patients. Coron Artery Dis 2009;20(5):309-16.

81. Schwarzer R, Siebert U. Methods, procedures, and contextual characteristics of health technology assessment and health policy decision making: Comparison of health technology assessment agencies in Germany, United Kingdom, France, and Sweden. Int J Technol Assess Health Care 2009;25(3):305-14.

80. Zechmeister I, Blasio BF, Garnett G, Neilson AR, Siebert U. Cost-effectiveness analysis of human papillomavirus-vaccination programs to prevent cervical cancer in Austria. Vaccine 2009;27(37):5133-41.

79. Siebert U, Sroczynski G, Aidelsburger P, Rossol S, Wasem J, Manns MP, McHutchison JG, Wong JB, German Hepatitis C Model (GEHMO) Group, International Hepatitis Interventional Therapy (IHIT) Group. Clinical effectiveness and cost-effectiveness of tailoring chronic hepatitis C treatment with peginterferon alpha-2b plus ribavirin to HCV genotype and early viral response: A decision analysis on new German guidelines. Pharmacoeconomics 2009;27(4):341-54.

78. Neumann A, Jahn R, Diehm C, Driller E, Hessel F, Lux G, Ommen O, Pfaff H, Siebert U, Wasem J, and on behalf of the Patient Care Evaluation-Peripheral Arterial Disease (PACE-PAD) Study Investigators. Presentation and medical management of peripheral arterial disease in general practice: rationale, aims, design and baseline results of the PACE-PAD Study. J Public Health 2009;17(2):127-35.

77. Göhler A, Geisler BP, Manne JM, Kosiborod M, Zhang Z, Weintraub WS, Spertus JA, Gazelle GS, Siebert U, Cohen DJ. Utility Estimates for Decision – Analytic Modeling in chronic heart failure – health states based on New York Heart Association classes and number of rehospitalizations. Value in Health 2009;12(1):185-7.

76. Geisler BP, Siebert U, Gazelle GS, Cohen DJ, Göhler A. Deterministic sensitivity analysis for First-Order Monte Carlo Simulations: A technical note. Value in Health 2009;12(1):96-7.

75. Mühlberger N, Schwarzer R, Lettmeier B, Sroczynski G, Zeuzem S, Siebert U. HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality. BMC Public Health 2009;9(1):34.

74. Sroczynski G, Esteban E, Conrads-Frank A, Schwarzer R, Muhlberger N, Wright D, Zeuzem S, Siebert U. Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection. Eur J Public Health 2009;19(3):245-53.

73. Stollenwerk B, Gerber A, Lauterbach KW, Siebert U. The German Coronary Artery Disease Risk Screening Model: Development, validation and application of a decision-analytic model for coronary artery disease prevention with statins. Med Decis Making 2009;29:619-33.

72. Siebert U, Conrads-Frank A, Schwarzer R, Lettmeier B, Sroczynski G, Zeuzem S, Mühlberger N. DALYs in chronic hepatitis C - a pan-European perspective In: Preedy VR, Watson RR, eds. Handbook of Disease Burdens and Quality of Life Measures. New York: Springer, 2009;1323-1334.

71. Siebert U. Die Bewertung der Kosteneffektivität von Impfungen unter Berücksichtigung von Public Health Aspekten. Public Health Forum 2009;17(2):9.e1-9.e3.

70. Göhler A, Conrads-Frank A, Worrell SS, Geisler BP, Halpern EF, Dietz R, Anker SD, Gazelle GS, Siebert U. Decision-analytic evaluation of the clinical effectiveness and cost-effectiveness of management programmes in chronic heart failure. Eur J Heart Fail 2008;10(10):1026-32

69. Boese-O’Reilly S, Drasch G, Lettmeier B, Roider G, Siebert U. Reply to the letter to the editor by J.G. Dorea “Health hazard for infants: Breast-milk mercury or non-breastfeeding? A dilemma for mothers exposed to mercury vapours”. Int J Hyg Environ Health 2008;212(2):235-7.

68. Institute for Quality and Efficiency in Health Care (IQWiG). Methods for assessment of the relation of benefits to costs in the German Statutory Health Care System. V. 1.0. (Members of the IQWiG International Expert Panel: Attella V, Caro J, Pouvourville G, Henry D, McGregor M, McGuire A, Nord E, Siebert U). Cologne: IQWiG, 2008;68.

67. Siebert U, Bornschein B, Schnell-Inderst P, Rieber J, Pijls N, Wasem J, Klauss V. [Measurement of fractional flow reserve to guide the decision on percutaneous coronary interventions] [German]. Health Technology Assessment Vol. 69 (Series of the German Institute for Medical Documentation and Information commissioned by the Federal Ministry of Health). Cologne, Germany: DIMDI, 2008;1-173.

66. Miksad RA, Zietemann V, Gothe R, Schwarzer R, Conrads-Frank A, Schnell-Inderst P, Stollenwerk B, Siebert U. Progression-free survival as a surrogate endpoint in advanced breast cancer. International Journal of Technology Assessment in Health Care 2008;24(4):371-83.

65. Lettmeier B; Mühlberger N, Schwarzer E, Sroczynski G, Wright D, Zeuzem S, Siebert U. Market Uptake of New Antiviral Drugs for the Treatment of Hepatitis C. Journal of Hepatology 2008;49(4):528-36.

64. Böse-O’Reilly S, Lettmeier B, Roider G, Siebert U, Drasch G. Mercury in breast milk – A health hazard for infants in gold mining areas? Int J Hyg Environ Health 2008:211(5-6):615-23.

63. Ammenwerth E, Schnell-Inderst P, Machan C, Siebert U. The Effect of Electronic Prescribing on Medication Errors and Adverse Drug Events: A Systematic Review. J Am Med Inform Assoc. 2008;15(5):585-600

62. Drummond M, Schwartz JS, Jönsson B, Luce B, Neumann P, Siebert U, Sullivan S. Response from the authors of “Key principles for the improved conduct of health technology assessments for resource allocation decisions”. [Letter] Int J Technol Assess Health Care 2008;24(3):367-8.

61. Drummond MF, Schwartz JS, Jönsson B, Luce BR, Neumann PJ, Siebert U, Sullivan SD. Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care 2008;24(3):244-58; discussion 362-8.

60. Bose-O’Reilly S, Lettmeier B, Gothe RM, Beinhoff C, Siebert U, Drasch G. Mercury as a serious health hazard for children in gold mining areas. Environmental Research 2008; 107(1):89-97.

59. Mühlberger N, Sroczynski G, Esteban E, Mittendorf T, Miksad RA, Siebert U. Cost-effectiveness of primarily human papillomavirus-based cervical cancer screening in settings with currently established Pap screening: A systematic review commissioned by the German Federal Ministry of Health. International Journal of Technology Assessment in Health Care 2008;24(2):184-92

58. König A, Kilian E, Sohn HY, Rieber J, Schiele TM, Siebert U, Gothe RM, Reichart B, Klauss V. Assessment and characterization of time-related differences in plaque composition by intravascular ultrasound-derived radiofrequency analysis in heart transplant recipients. Journal of Heart & Lung Transplantation 2008;27(3):302-9.

57. Böse-O´Reilly S, Wermuth I, Hellmann J, Siebert U, Lob-Corzilius T. [Promotion of breast feeding in paediatric outpatient settings]. [German] Gesundheitswesen 2008;70(Suppl 1):S34-36.

56. Janne d’Othée B, Siebert U, Cury R, Jadvar H, Dunn EJ, Hoffmann U. A systematic review on diagnostic accuracy of CT-based detection of significant coronary artery disease. Eur J Radiol 2008;65(3):449-61.

55. Stempfle HU, Alt A, Stief J, Siebert U. The Munich score: a clinical index to predict survival in ambulatory patients with chronic heart failure in the era of new medical therapies. Journal of Heart & Lung Transplantation 2008;27(2):222-8.

54. Dodel R, Peter H, Spottke A, Althaus A, Siebert U, Walbert T, Kesper K, Becker HF, Mayer G. Health-Related Quality of Life in Patients with Narcolepsy. Sleep Medicine 2007:8(7-8):733-41.

53. Meissner OA, Schmedt CG, Hunger K, Hetterich H, Sroka R, Rieber J, Babaryka G, Steckmeier BM, Reiser M, Siebert U, Mueller-Lisse U. Endovascular optical coherence tomography ex vivo: venous wall anatomy and tissue alterations after endovenous therapy. Eur Radiol 2007;17(9):2384-93.

52. Schneider A, Schwarz TF, Hammerschmidt T, Rash RM, Siebert U. [Treatment patterns and costs of unclear and abnormal cervical conditions in Germany]. [German] Geburtshilfe und Frauenheilkunde 2007;67(8):859-865.

51. Schneider A, Hammerschmidt T, Schwarz TF, Rogoza RM, Ferko N, Siebert U. [Long-term public health impact of vaccination against cervical cancer in Germany]. [German] Geburtshilfe und Frauenheilkunde 2007;67(8):850-858.

50. Schneider A, Schwarz TF, Hammerschmidt T, Siebert U. [Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany]. [German] Medizinische Klinik 2007; 102(7):515-23.

49. Fearon WF, Tonino PA, De Bruyne B, Siebert U, Pijls NHJ, for the FAME Study Investigators. Rationale and Design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) Study. American Heart Journal 2007;154(4):632-6

48. König A, Leibig M, Rieber J, Schiele TM, Theisen K, Siebert U, Gothe RM, Klauss V. Randomized comparison of dexamethasone-eluting stents with bare metal stent implantation in patients with acute coronary syndrome: serial angiographic and sonographic analysis. American Heart Journal 2007;153(6):979.e1-8.

47. Müller T, Koppikar S, Taylor RM, Carragher F, Schlenck B, Heinz-Erian P, Kronenberg F, Ferenci P, Tanner S, Siebert U, Staudinger R, Mieli-Vergani G, Dhawan A. Re-evaluation of the penicillamine challenge test in the diagnosis of Wilson’s disease in children. J Hepatol 2007; 47(2):270-6.

46. Dodel R, Peter H, Spottke A, Althaus A, Siebert U, Walbert T, Kesper K, Becker HF, Mayer G. Health-Related Quality of Life in Patients with Narcolepsy. Sleep Medicine 2007 [in press]

45. Schrag A, Dodel R, Spottke A, Bornschein B, Siebert U, Quinn NP Titel: Rate of clinical progression in Parkinson’s disease. A prospective study. Mov Disord 2007; 22(7):938-45.

44. Meissner OA, Schmedt CG, Hunger K, Hetterich H, Sroka R, Rieber J, Babaryka G, Steckmeier BM, Reiser M, Siebert U, Mueller-Lisse U. Endovascular optical coherence tomography ex vivo: venous wall anatomy and tissue alterations after endovenous therapy. Eur Radiol. 2007; 17(9):2384-93.

43. Basner M, Siebert U. Markov processes for prediction of aircraft-noise effects on sleep [Original title: Markov-Prozesse zur Vorhersage fluglaermbedingter Schlafstoerungen]. Somnologie 2006;10:176-191.

42. Siebert U. Cost-Effectiveness. In: King and Yeung (eds.). Interventional Cardiology. McGraw-Hill, New York: 2007, 767-82.

41. Siebert U. [Decision Analysis]: In: Schlipköter U, Wildner M (eds.): [Manual of Infectious Diseases Epidemiology] Hans Huber, Bern: 2006; 87-95.

40. Castelnuovo E, Thompson-Coon J, Pitt M, Cramp M, Siebert U, Price A, Stein K. The costeffectiveness of testing for hepatitis C in former injecting drug users. Health Technol Assess 2006;10(32):1-112.

39. Göhler A, Januzzi JL, Worrell SS, Osterziel KJ, Gazelle GS, Dietz R, Siebert U. A Systematic Meta-Analysis of the Efficacy and Heterogeneity of Disease Management Programs in Congestive HeartFailure. J Cardiac Failure 2006, 12 (7): 554-67

38. Siebert U, Januzzi JL Jr, Beinfeld MT, Cameron R, Gazelle GS. Cost-effectiveness of Using N-terminal pro-Brain Natriuretic Peptide to Guide the Diagnostic Assessment and Management of Dyspneic Patients in the Emergency Department. American Journal of Cardiology, 2006, 98 (6): 800-5

37. Zietemann V, Zietemann P, Weitkunat R, Kwetkat A. Depressionshäufigkeit in Abhängigkeit von verschiedenen Erkrankungen bei geriatrischen Patienten. Der Nervenarzt 2006

36. Thompson Coon J, Castelnuovo E, Pitt M, Cramp M, Siebert U, Stein K. Case finding for hepatitis C in primary care: a cost utility analysis. Fam Pract 2006;23(4):393-406.

35. Basner M, Siebert U. Markov processes for prediction of aircraft-noise effects on sleep [Original title: Markov-Prozesse zur Vorhersage fluglaermbedingter Schlafstoerungen]. Somnologie 2006;10:176-191.

34. Siebert U. Entscheidungsanalysen in HTA. Ziele, Stärken, Limitationen. HTA-Newsletter ITA/Österreichische Akademie der Wissenschaften 2006 (45): 1-2. http://epub.oeaw.ac.at/ita/htanewsletter/ htaNL0306.pdf

33. Rohde V, Grabein K, Hessel F, Siebert U, Wasem J. Orchiektomie versus medikamentöse Therapie mit LH-RH-Analoga zur Behandlung des fortgeschrittenen Prostatakarzinoms. Health Technology Assessment Vol. 140. Serie des Deutschen Instituts für Medizinische Dokumentation und Information, im Auftrag des Bundesministeriums für Gesundheit. Köln: DIMDI, 2006

32. Sroczynski G, Rafetseder O. Jonas S., Siebert U. Antivirale Kombinationstherapie bei Patienten mit chronischer Hepatitis C in Österreich. Gesundheitsökonomische Evaluation der Kombinationstherapie mit Interferon/Peginterferon und Ribavirin. ITA-Projektbericht Nr. b29 . (48 pages. Vienna: Institut für Technologiefolgenabschätzung, Österreichische Akademie der Wissenschaften, 2006.

31. Hoffmann U, Pena AJ, Cury RC, Abbara S, Ferencik M, Moselewski F, Siebert U, Brady TJ, Nagurney JT. Cardiac CT in emergency department patients with acute chest pain. Radiographics 2006;26(4):963-978; discussion 979-80.

30. Cury RC, Cattani CA, Gabure LA, Racy DJ, de Gois JM, Siebert U, Lima SS, Brady TJ. Diagnostic Performance of Stress Perfusion and Delayed-Enhancement MR Imaging in Patients with Coronary Artery Disease. Radiology 2006;240(1):39-45.

29. Rieber J. Huber A, Erhard I, Mueller S, Schweyer M, Koenig A, Schiele TM, Theisen K, Siebert U, Schoenberg SO, Reiser M, Klauss V. Cardiac magnetic resonance perfusion imaging for the functional assessment of coronary artery disease: A comparison with coronary angiography and fractional flow reserve. European Heart Journal 2006;27(12):1456-71.

28. Siebert U, Sroczynski G, Hillemanns P, Engel J, Stabenow R, Stegmaier C, Voigt K, Gibis B, Hölzel D, Goldie SJ. The German Cervical Cancer Screening Model: Development and validation of a decisionanalytic model for cervical cancer screening in Germany. Eur J Pub Health 2006;16(2):185-92.

27. Hoffmann U. Siebert U. Bull-Stewart A. Achenbach S. Ferencik M. Moselewski F. Brady TJ. Massaro JM. O’Donnell CJ. Evidence for lower variability of coronary artery calcium mineral mass measurements by multi-detector computed tomography in a community-based cohort–consequences for progression studies. Eur J Radiol 2006;57(3):396-402.

26. Meissner OA. Rieber J. Babaryka G. Oswald M. Reim S. Siebert U. Redel T. Reiser M. Mueller-Lisse U. Intravascular optical coherence tomography: comparison with histopathology in atherosclerotic peripheral artery specimens. J Vasc Interv Radiol 2006;17(2):343-9.

25. Meissner OA. Rieber J. Babaryka G. Oswald M. Reim S. Siebert U. Redel T. Eibel R. Mueller-Lisse U. Reiser M. Mueller-Lisse UG. [Intravascular optical coherence tomography: differentiation of atherosclerotic plaques and quantification of vessel dimensions in crural arterial specimens]. [German] Rofo 2006;178(2):214-20.

24. Wasem J. Sroczynski G. Aidelsburger P. Buchberger B. Hessel F. Conrads-Frank A. Peters-Blöchinger A. Kurth BM. Wong JB. Rossol S. Siebert U. [Health economics of chronic infectious diseases: the example of hepatitis C]. [German]